PIB News
TDB-DST and Peptris sign ₹86 crore agreement to boost AI drug discovery efforts
The Technology Development Board (TDB) of the Government of India has signed an ₹86 crore agreement with Peptris Technologies in Bengaluru to enhance AI-driven drug discovery. This funding, part of the Research Development and Innovation (RDI) Fund, will support the VIGOR project, which aims to advance four AI-discovered drug candidates through preclinical development. The total cost of the project is ₹172 crore, and it seeks to elevate the candidates from Technology Readiness Level (TRL)-4 to TRL-6. This initiative is part of India's efforts to strengthen its pharmaceutical innovation ecosystem by leveraging artificial intelligence in drug development.
The Radius summarizes this story. Read the original report from PIB News.
Read Full